JF
IART icon

Jump Financial’s Integra LifeSciences IART Stock Holding History

Jump Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,911
Closed -$422K – 2010
2024
Q1 		$422K Buy
11,911
+7,270
+157% +$291K 0.01% 1276
2023
Q4 		$202K Buy
+4,641
New +$183K 0.01% 1559
2023
Q3 		– Sell
-48,507
Closed -$2M – 2017
2023
Q2 		$2M Buy
48,507
+41,554
+598% +$2M 0.07% 391
2023
Q1 		$399K Buy
+6,953
New +$392K 0.02% 994
2022
Q4 		– Sell
-68,300
Closed -$2.89M – 1780
2022
Q3 		$2.89M Buy
68,300
+22,473
+49% +$1.15M 0.11% 263
2022
Q2 		$2.48M Buy
45,827
+30,170
+193% +$1.81M 0.11% 260
2022
Q1 		$1.01M Buy
+15,657
New +$1.03M 0.04% 523

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Jump Financial's IART Position: Q2 2024 in Review

Jump Financial sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 11,911 shares — an estimated $422K sold.

Jump Financial first reported a position in IART in Q1 2022 and held it in 7 quarters. The position peaked at $2.89M in Q3 2022. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Jump Financial reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 11,911 Integra LifeSciences shares in Q2 2024, an estimated $422K.
  • Jump Financial first reported a position in Integra LifeSciences in Q1 2022 and held it in 7 quarters.
  • Jump Financial's Integra LifeSciences position peaked at $2.89M in Q3 2022.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.